Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach
NCT ID: NCT05237063
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
2000 participants
INTERVENTIONAL
2021-01-13
2031-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study follow-up visit schedule corresponds to the visits usually scheduled as part of patient care: 1 year from the inclusion visit (A1), 3 years (A3) then 5 years (A5). Samples for research (additional volume of blood, urine) will be taken by a registered nurse along with the routine check-up samples.Samples intended for research will be sent by staff to the Biobanque de Picardie (CHU Amiens-Picardie) for processing and conservation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care
NCT06367894
Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study
NCT03437057
The Use of the "Comprehensive Complication Index" for Urinary Lithiasis Surgery.
NCT05593783
Bone Mineral Density and Vascular Calcifications in the Population of Lithiasis Patients With Idiopathic Hypercalciuria
NCT04770506
Ultrasound Imaging of Kidney Stones and Lithotripsy
NCT02214836
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood and urine samples
Additional Blood and urine samples will be collected at inclusion, 1, 3 and 5 years follow up visits
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Persons able to understand and object to the information provided (at the discretion of the investigator)
* Patient affiliated to social security
* Patient agreeing to sign the informed consent form
* patient having presented at least one renal colic attack before inclusion
Exclusion Criteria
* Persons deprived of liberty,
* Adults under legal protection guardianship, or curators or unable to express their consent.
* Patient refusing to participate in the study
* Patient in an emergency situation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Pasteur de Lille
OTHER
Université de Lille
OTHER
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Nord
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2021_843_0137
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.